The increased risk of adverse events associated with HIV infection has implications for clinical monitoring of these patients and this work which studies a patient cohort with a relatively high CD4 count, confirms the need for clinicians to ensure that TB programmes focus on this high-risk group even in cases where the CD4+ is preserved. The gene discussed is CD4; the disease is HIV infectious disease.